4DMedical Statistics

Total Valuation

4DMedical has a market cap or net worth of AUD 117.11 million. The enterprise value is 105.98 million.

Market Cap	117.11M
Enterprise Value	105.98M

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

4DMedical has 450.42 million shares outstanding. The number of shares has increased by 46.00% in one year.

Current Share Class	n/a
Shares Outstanding	450.42M
Shares Change (YoY)	+46.00%
Shares Change (QoQ)	+67.40%
Owned by Insiders (%)	3.72%
Owned by Institutions (%)	1.24%
Float	362.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.92
PB Ratio	1.80
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.68
EV / Sales	18.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.49

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.08.

Current Ratio	1.03
Quick Ratio	0.88
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.16
Interest Coverage	-169.85

Financial Efficiency

Return on equity (ROE) is -52.37% and return on invested capital (ROIC) is -35.74%.

Return on Equity (ROE)	-52.37%
Return on Assets (ROA)	-23.32%
Return on Invested Capital (ROIC)	-35.74%
Return on Capital Employed (ROCE)	-57.35%
Revenue Per Employee	40,393
Profits Per Employee	-272,689
Employee Count	145
Asset Turnover	0.05
Inventory Turnover	0.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.40% in the last 52 weeks. The beta is 1.36, so 4DMedical's price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	-58.40%
50-Day Moving Average	0.40
200-Day Moving Average	0.47
Relative Strength Index (RSI)	30.49
Average Volume (20 Days)	1,278,157

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, 4DMedical had revenue of AUD 5.86 million and -39.54 million in losses. Loss per share was -0.09.

Revenue	5.86M
Gross Profit	5.48M
Operating Income	-45.85M
Pretax Income	-39.53M
Net Income	-39.54M
EBITDA	-45.16M
EBIT	-45.85M
Loss Per Share	-0.09

Full Income Statement

Balance Sheet

The company has 15.95 million in cash and 4.82 million in debt, giving a net cash position of 11.13 million or 0.02 per share.

Cash & Cash Equivalents	15.95M
Total Debt	4.82M
Net Cash	11.13M
Net Cash Per Share	0.02
Equity (Book Value)	59.86M
Book Value Per Share	0.14
Working Capital	631,450

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -30.28 million and capital expenditures -96,029, giving a free cash flow of -30.37 million.

Operating Cash Flow	-30.28M
Capital Expenditures	-96,029
Free Cash Flow	-30.37M
FCF Per Share	-0.07

Full Cash Flow Statement

Margins

Gross Margin	93.60%
Operating Margin	-782.83%
Pretax Margin	-674.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

4DMedical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-46.00%
Shareholder Yield	-46.00%
Earnings Yield	-33.76%
FCF Yield	-25.93%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

4DMedical has an Altman Z-Score of -0.46. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.46
Piotroski F-Score	n/a